Sponsored Links
| New Therapeutic Agent In Development Shows Statistically Significant Positive Outcomes In Patients With Debilitating, Life-threatening Blood Cancer |
 |
 |
 |
| Medical News - Hematology | |||
|
The largest clinical program to date in patients with a potentially life-threatening blood cancer known as myelofibrosis (MF) has shown that a new therapeutic candidate, ruxolitinib, provided clinical benefits to patients compared to placebo and best available therapy. These benefits included reduction in spleen size and relief of debilitating symptoms... Read more: Blood / Hematology News From Medical News Today
|